journal article·2012-08-28

Acid Degradable Cross-Linked Micelles for the Delivery of Cisplatin: A Comparison with Nondegradable Cross-Linker

Vien T. Huynh, Sandra Binauld, Paul L. de Souza, Martina H. Stenzel

Chemistry of Materials· Volume 24· Issue 16
Publisher page

Abstract

Well-defined and nontoxic cross-linked polymeric micelles, containing either permanent or acid degradable cross-linkers, were employed for efficient intracellular delivery of cisplatin. The self-assembled structures were generated from triblock copolymers of poly(oligo(ethylene glycol) methylether methacrylate)- block -poly( N -hydroxysuccinic methacrylate)- block -poly(1,1-di- tert -butyl 3-(2-(methacryloyloxy)ethyl) butane-1,1,3-tricarboxylate) (POEGMEMA- b -PNHSMA- b -PMAETC) loaded with cisplatinum. The polymeric micelles were subsequently cross-linked via a reaction between pendant activated esters at the nexus core of the triblock copolymer using acid degrdabale ketal diamino cross-linkers. An in vitro study confirmed that both uncross-linked and cross-linked micelles prior to the loading of the platinum drug were nontoxic against OVCAR-3 cells even at high polymer concentration (around 300 μg mL –1 ). The drug loaded cross-linked platinum polymeric micelles were superior to the uncross-linked platinum polymeric micelles in terms of cytotoxicity against OVCAR-3, due to a higher cellular uptake. Although there was no significant difference in cytotoxicity of cross-linked platinum polymeric micelles using different cross-linkers (permanent and acid cleavable) after 72 h of exposure, the difference was noticeable after 24 h of incubation, highlighting a much higher activity for acid degradable cross-linked micelles with conjugated platinum drugs. Moreover, the clonogenic assay suggested that cross-linked micelle loaded platinum drugs, in contrast to uncross-linked micelles, can effectively inhibit the OVCAR-3 cell regrowth for an extended period of time (10 days), even at very low micellar concentrations. In summary, acid degradable linkers ensure high cellular uptake compared to uncross-linked micelles but also lead to a faster drug action in comparison to a permanently cross-linked micelle.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Lanthanide and Transition Metal Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre for Advanced Macromolecular Design (CAMD), The University of New South Wales, Sydney NSW 2052, Australia

Liverpool Hospital Clinical School and Molecular Medicine Research Group, University of Western Sydney, Sydney NSW 2170, Australia

References (60)

Show source-provided references
1. Kelland L. · Nat. Rev. Cancer · 2007 · 7 · 57310.1038/nrc2167 ↗
2. Yokoyama M. · J. Controlled Release · 1996 · 39 · 35110.1016/0168-3659(95)00165-4 ↗
3. Weiss R. B. · Drugs · 1993 · 46 · 36010.2165/00003495-199346030-00003 ↗
4. Stewart D. J. · CRC Cr. Rev. Oncol.-Hematol. · 2007 · 63 · 1210.1016/j.critrevonc.2007.02.001 ↗
5. Roberts J. D. · J. Inorg. Biochem. · 1999 · 77 · 5110.1016/S0162-0134(99)00147-6 ↗
6. Muggia F. · CRC Crit. Rev. Oncol.-Hematol. · 2005 · 53 · 110.1016/j.critrevonc.2004.11.007 ↗
7. Matsumura Y. · Jpn. J. Clin. Oncol. · 2008 · 38 · 79310.1093/jjco/hyn116 ↗
8. Kratz F. · Cancer J. - France · 1998 · 11 · 176
9. Reedijk J. · Eur. J. Inorg. Chem. · 2009 · 130310.1002/ejic.200900054 ↗
10. Florea A.-M. · Cancers · 2011 · 3 · 135110.3390/cancers3011351 ↗
11. Huynh V. T. · Biomacromolecules · 2012 · 13 · 101010.1021/bm2017299 ↗
12. Kim Y. · J. Mater. Chem. · 2011 · 21 · 1277710.1039/c1jm11062d ↗
13. Huynh V. T. · Macromolecules · 2011 · 44 · 788810.1021/ma2016503 ↗
14. Huynh V. T. · Biomacromolecules · 2011 · 12 · 173810.1021/bm200135e ↗
15. Duong H. T. T. · Macromolecules · 2011 · 44 · 800810.1021/ma201085z ↗
16. Zhang L. · Aust. J. Chem. · 2009 · 62 · 81310.1071/CH09108 ↗
17. Wang Y.-C. · J. Polym. Sci., Part A: Polym. Chem. · 2009 · 47 · 616810.1002/pola.23660 ↗
18. Chan Y. · Biomacromolecules · 2008 · 9 · 182610.1021/bm800043n ↗
19. Stenzel M. H. · Chem. Commun. · 2008 · 348610.1039/b805464a ↗
20. Du Y.-Z. · ACS Nano · 2010 · 4 · 689410.1021/nn100927t ↗
21. Talelli M. · Adv. Drug Delivery Rev. · 2010 · 62 · 23110.1016/j.addr.2009.11.029 ↗
22. Poland D. C. · J. Phys. Chem. · 1965 · 69 · 243110.1021/j100891a055 ↗
23. Croy S. R. · Curr. Pharm. Design · 2006 · 12 · 466910.2174/138161206779026245 ↗
24. Bontha S. · J. Controlled Release · 2006 · 114 · 16310.1016/j.jconrel.2006.06.015 ↗
25. Bronich T. K. · J. Am. Chem. Soc. · 2005 · 127 · 823610.1021/ja043042m ↗
26. Duong H. T. T. · Biomacromolecules · 2010 · 11 · 229010.1021/bm100396s ↗
27. Hales M. · Langmuir · 2004 · 20 · 1080910.1021/la0484016 ↗
28. O’Reilly R. K. · Chem. Soc. Rev. · 2006 · 35 · 106810.1039/b514858h ↗
29. Rodriguez-Hernandez J. · Biomacromolecules · 2005 · 6 · 221310.1021/bm0501499 ↗
30. Kim Y. · Biomacromolecules · 2012 · 13 · 81410.1021/bm201730p ↗
31. Read E. S. · Chem. Commun. · 2007 · 29 · 302110.1039/b701217a ↗
32. Zhang L. · Biomacromolecules · 2007 · 8 · 289010.1021/bm070370g ↗
33. Zhang L. · Biomacromolecules · 2008 · 9 · 332110.1021/bm800867n ↗
34. O’Reilly R. K. · J. Polym. Sci., Part A: Polym. Chem. · 2006 · 44 · 520310.1002/pola.21602 ↗
35. Joralemon M. J. · Bioconjugate Chem. · 2005 · 16 · 124610.1021/bc0501505 ↗
36. Lee S. J. · Biomacromolecules · 2011 · 12 · 122410.1021/bm101517x ↗
37. Xu X. · Macromolecules · 2011 · 44 · 132710.1021/ma102804h ↗
38. Wike-Hooley J. L. · Radiother. Oncol. · 1984 · 2 · 34310.1016/S0167-8140(84)80077-8 ↗
39. Zhang L. · Macromol. Rapid Commun. · 2008 · 29 · 12310.1002/marc.200700663 ↗
40. Gu J. · Biomacromolecules · 2007 · 9 · 25510.1021/bm701084w ↗
41. Ding C. · Bioconjugate Chem. · 2009 · 20 · 116310.1021/bc800563g ↗
42. Mitsukami Y. · Macromolecules · 2001 · 34 · 224810.1021/ma0018087 ↗
43. Oae S. · Tetrahedron · 1972 · 28 · 320310.1016/S0040-4020(01)93661-0 ↗
44. Greene A. C. · Macromolecules · 2011 · 44 · 194210.1021/ma102869y ↗
45. Wang L. · Colloids Surf., B · 2009 · 74 · 28410.1016/j.colsurfb.2009.07.032 ↗
46. Colombani O. · Macromolecules · 2007 · 40 · 433810.1021/ma0609578 ↗
47. Skehan P. · J. Natl. Cancer Inst. · 1990 · 82 · 110710.1093/jnci/82.13.1107 ↗
48. Xing R. · J. Inorg. Biochem. · 2009 · 103 · 103910.1016/j.jinorgbio.2009.05.001 ↗
49. Liebmann J. E. · Br. J. Cancer · 1993 · 68 · 110410.1038/bjc.1993.488 ↗
50. Albertin L. · Polymer · 2005 · 46 · 283110.1016/j.polymer.2005.02.005 ↗
51. Gregory A. · Prog. Polym. Sci. · 2012 · 37 · 3810.1016/j.progpolymsci.2011.08.004 ↗
52. Nishiyama N. · Cancer Res. · 2003 · 63 · 8977
53. Izumi H. · Cancer Treat. Rev. · 2003 · 29 · 54110.1016/S0305-7372(03)00106-3 ↗
54. Eskelinen E. L. · Trends Cell Biol. · 2003 · 13 · 13710.1016/S0962-8924(03)00005-9 ↗
55. Gregory A. · Expert Opin. Drug Delivery · 2011 · 8 · 23710.1517/17425247.2011.548381 ↗
56. Okazaki S. · J. Controlled Release · 2003 · 91 · 235
57. Nishiyama, N.; Kataoka, K.Polymer Therapeutics II: Polymers as Drugs, Conjugates and Gene Delivery Systems; Advances in Polymer Science;Springer: 2006; Vol.193, p67.
58. Blanco E. · Exp. Biol. Med. · 2009 · 234 · 12310.3181/0808-MR-250 ↗
59. Subramaniam D. · Cancer Res. · 2008 · 68 · 196210.1158/0008-5472.CAN-07-6011 ↗
60. Franken N. A. P. · Nat. Protoc. · 2006 · 1 · 231510.1038/nprot.2006.339 ↗